Zusammenfassung
Die Diagnose eines Morbus Crohn wurde früher in vielen Fällen mit einer deutlichen Zeitverzögerung gestellt. Dieser allgemein verbreitete Eindruck ist heute so nicht mehr zutreffend. Die Möglichkeit des Vorliegens einer chronisch-entzündlichen Darmerkrankung wird bei entsprechender Symptomatik zumeist schnell in die differenzialdiagnostischen Überlegungen einbezogen und kann dann in der Regel auch zügig durch die sonografische, endoskopische und radiologische Diagnostik bestätigt werden (Pimentel et al. 2000).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Ananthakrishnan AN, Weber LR, Knox JF, Skaros S, Emmons J, Lundeen S, Issa M, Otterson MF, Binion DG (2008) Permanent work disability in Crohn’s disease. Am J Gastroenterol 103:154–161
Andersson P, Olaison G, Hallbook O, Sjodahl R (2002a) Segmental resection or subtotal colectomy in Crohn’s colitis? Dis Colon Rectum 45:47–53
Andersson P, Olaison G, Bodemar G, Nystrom PO, Sjodahl R (2002b) Surgery for Crohn colitis over a twenty-eight-year period: fewer stomas and the replacement of total colectomy by segmental resection. Scand J Gastroenterol 37:68–73
Ausfeld-Hafter B, Hoffmann S, Seibold F, Quattropani C, Heer P, Straumann A (2005) Status of alternative medicine in Crohn disease and ulcerative colitis patients: a questionnaire survey. Forsch Komplementarmed Klass Naturheilkd 12:134–138
Baars JE et al (2017) Double-balloon enteroscopy-assisted dilatation avoids surgery for small bowel strictures: a systematic review. World J Gastroenterol 23:8073–8081
Baird DD, Narendranathan M, Sandler RS (1990) Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 99:987–994
Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444
Borley NR, Mortensen NJ, Chaudry MA, Mohammed S, Warren BF, George BD, Clark T, Jewell DP, Kettlewell MG (2002) Recurrence after abdominal surgery for Crohn’s disease: relationship to disease site and surgical procedure. Dis Colon Rectum 45:377–383
Brandt LJ, Estabrook SG, Reinus JF (1995) Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn’s disease. Am J Gastroenterol 90:1918–1922
Burr NE et al (2019) Decreasing risk of first and subsequent surgeries in patients with Crohn’s disease in England From 1994 through 2013. Clin Gastroenterol Hepatol (in press)
Casellas F, Rodrigo L, Nino P, Pantiga C, Riestra S, Malagelada JR (2007) Sustained improvement of health-related quality of life in Crohn’s disease patients treated with infliximab and azathioprine for 4 years. Inflamm Bowel Dis 13:1395–1400
Cosnes J, Beaugerie L, Carbonnel F, Gendre JP (2001) Smoking cessation and the course of Crohn’s disease: an intervention study. Gastroenterology 120:1093–1099
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP (2002) Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis 8:244–250
Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J et al (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122:867–874
Dietz DW, Laureti S, Strong SA, Hull TL, Church J, Remzi FH, Lavery IC, Fazio VW (2001) Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg 192:330–337, discussion 337–338
Ekbom A, Helmick C, Zack M, Adami HO (1990) Increased risk of large-bowel cancer in Crohn’s disease with colonic involvement. Lancet 336:357–359
Ekbom A, Helmick C, Zack M, Adami HO (1991) Extracolonic malignancies in inflammatory bowel disease. Cancer 67:2015–2019
Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Crane M, Kanik KS, Chrousos GP (2001) IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933–4938
Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn’s disease: a statistical study of 615 cases. Gastroenterology 68:627–635
Faubion WA Jr, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Sandborn WJ (2001) The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 121:255–260
Fonager K, Sorensen HT, Olsen J, Dahlerup JF, Rasmussen SN (1998) Pregnancy outcome for women with Crohn’s disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 93:2426–2430
Gasche C, Scholmerich J, Brynskov J, D’Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ et al (2000) A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15
Goebell H (1988) Different activity indices in Crohnʼs disease and their possible role. In: Goebell H, Peskar BM, Malchow H (Hrsg) Inflammatory bowel disease: basic research and clinical implications. MTP Press, Lancaster, S 253–258
Guassora AD, Kruuse C, Thomsen OO, Binder V (2000) Quality of life study in a regional group of patients with Crohn disease. A structured interview study. Scand J Gastroenterol 35:1068–1074
Hassan C, Zullo A, De Francesco V, Ierardi E, Giustini M, Pitidis A, Taggi F, Winn S, Morini S (2007) Systematic review: endoscopic dilatation in Crohn’s disease. Aliment Pharmacol Ther 26:1457–1464
Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ (2007) Mortality by medication use among patients with inflammatory bowel disease, 1996–2003. Gastroenterology 133:1779–1786
Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW (1994) Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn’s Relapse Prevention Trial Study Group. Gastroenterology 106:287–296
Irvine EJ, Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Nilsson LG, Persson T (2000) Quality of life rapidly improves with budesonide therapy for active Crohn’s disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis 6:181–187
Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF et al (2007) Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 5:345–351
Jantschek G, Zeitz M, Pritsch M, Wirsching M, Klor HU, Studt HH, Rasenack J, Deter HC, Riecken EO, Feiereis H et al (1998) Effect of psychotherapy on the course of Crohn’s disease. Results of the German prospective multicenter psychotherapy treatment study on Crohn’s disease. German Study Group on Psychosocial Intervention in Crohn’s Disease. Scand J Gastroenterol 33:1289–1296
Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ 3rd, Munkholm P et al (2006) Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology 130:1039–1046
Kane SV, Sable K, Hanauer SB (1998) The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study. Am J Gastroenterol 93:1867–1872
Khosla R, Willoughby CP, Jewell DP (1984) Crohn’s disease and pregnancy. Gut 25:52–56
Kratzer W, von Tirpitz C, Mason R, Reinshagen M, Adler G, Moller P, Rieber A, Kachele V (2002) Contrast-enhanced power Doppler sonography of the intestinal wall in the differentiation of hypervascularized and hypovascularized intestinal obstructions in patients with Crohn’s disease. J Ultrasound Med 21:149–157, quiz 158–149
Krupnick AS, Morris JB (2000) The long-term results of resection and multiple resections in Crohn’s disease. Semin Gastrointest Dis 11:41–51
Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J (2001) Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut 49:777–782
Ma C et al (2017) Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol 112:1840–1848
Munkholm P, Langholz E, Davidsen M, Binder V (1994) Frequency of glucocorticoid resistance and dependency in Crohn’s disease. Gut 35:360–362
Nyhlin N, Bohr J, Eriksson S, Tysk C (2006) Systematic review: microscopic colitis. Aliment Pharmacol Ther 23:1525–1534
Panes J et al (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388:1281–1290
Park SH et al (2018) Computed tomography and magnetic resonance small bowel enterography: current status and future trends focusing on Crohn’s disease. Gastroenterol Clin North Am 47:475–499
Persson PG, Bernell O, Leijonmarck CE, Farahmand BY, Hellers G, Ahlbom A (1996) Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology 110:1339–1345
Pimentel M, Chang M, Chow EJ, Tabibzadeh S, Kirit-Kiriak V, Targan SR, Lin HC (2000) Identification of a prodromal period in Crohn’s disease but not ulcerative colitis. Am J Gastroenterol 95:3458–3462
Rodemann JF, Dubberke ER, Reske KA, da Seo H, Stone CD (2007) Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 5:339–344
Simillis C, Yamamoto T, Reese GE, Umegae S, Matsumoto K, Darzi AW, Tekkis PP (2008) A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 103:196–205
Sostegni R, Daperno M, Scaglione N et al (2003) Crohn’s disease: Monitoring disease activity. Aliment Pharmacol Ther 17:11–17
von Wietersheim J, Overbeck A, Kiel K, Kohler T, Jantschek G, Feiereis H (1994) The significance of recurrence-inducing events for patients with chronic inflammatory bowel diseases. Results of a prospective longitudinal study over three years. Psychother Psychosom Med Psychol 44:58–64
Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H (1993) Intestinal permeability and the prediction of relapse in Crohn’s disease. Lancet 341:1437–1439
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Reinshagen, M. (2020). Klinik des Morbus Crohn. In: Hoffmann, J.C., Klump, B., Kroesen, A., Siegmund, B. (eds) Chronisch-entzündliche Darmerkrankungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59104-8_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-59104-8_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59103-1
Online ISBN: 978-3-662-59104-8
eBook Packages: Medicine (German Language)